Who we are?
Genoks was founded in 2008 as R&D laboratory and produced PCR and RT-PCR based diagnostic kits and DNA isolation kits for purpose of use in molecular biology and genetics research between 2008-2010. These are registered in the National Data Bank and used by Turkey’s leading institutes and institutions. Genoks’ HQ has a laboratory and office area of 1,100 m² that it continues to serve with more than 70 employees who are experts in their fields, both in the country and abroad.

What we do?

Sharing its technology with 10 countries, more than 500 hospitals and approximately 3000 physicians, Genoks has carried out more than 80,000 NGS tests, with its high-tech sequencing platforms, local servers and NGS database over 400,000 Gb. Genoks leads to contribute human healthcare not only in Turkey but also in the nearby geography. It is aimed to become one of the largest genome centers in EEMEA.
Genoks which started to routinely use the NIPT test for the first time in Turkey by using Next Generation Sequencing technology with its technology transfers as Genetics Diagnosis Center. Genoks presents valuable comprehensive genetic testing panels which contains Non-invasive prenatal Testing, Whole Genome Sequencing, Whole Exome Sequencing, Cancer Genetics, Carrier Screening Test, Newborn Screening Test, Monogenic Disorder Panels, Metabolic Disease Testing Panels, Neurodegenerative Disease Testing Panels, Ophthalmology Genetics, Sports Genetics, Pharmacogenetics and so on.


Who we Are?
Who we Are?
Who we Are?
Who we Are?

Our aims

Genoks aims to expand the clinical genetic testing market with its technological infrastructure, as well as to increase its reputation by participating in international projects.

Our missions

Our aim is to provide a fast, competitive service that meets the expectations of our customers with a dynamic teamwork for a healthy life, which is the most basic need and right of people. Genoks Genetic Diseases Evaluation Center is licensed by the Ministry of Health of the Republic of Turkey.